09.01.2013 Views

Seminars - Malaghan Institute of Medical Research

Seminars - Malaghan Institute of Medical Research

Seminars - Malaghan Institute of Medical Research

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Asthma and Parasitic<br />

Diseases<br />

Clinical Perspective and Overview <strong>of</strong> Disease Project One: The Basic Biology <strong>of</strong> the Th2<br />

Asthma is a chronic inflammatory disease <strong>of</strong> the airways<br />

in the lungs characterised by periodic attacks <strong>of</strong> wheezing,<br />

shortness <strong>of</strong> breath, chest-tightness, and coughing. It is<br />

<strong>of</strong>ten triggered by harmless environmental stimulants<br />

setting <strong>of</strong>f the part <strong>of</strong> the immune response (termed<br />

the Th2 immune response) that is normally involved in<br />

protecting us against parasitic worms.<br />

New Zealand has one <strong>of</strong> the highest prevalence rates <strong>of</strong><br />

asthma in the world; affecting one in six adults and one in<br />

five children aged 6 to 14. Hospitalisation rates for asthma<br />

sufferers have more than doubled in the past 30 years,<br />

and the condition is conservatively estimated to cost<br />

New Zealand approximately $825 million per year.<br />

Although there are treatments available that reduce<br />

the frequency and severity <strong>of</strong> asthma attacks, there is<br />

currently no cure for this disease.<br />

We hope that by researching the underlying mechanisms<br />

<strong>of</strong> the Th2 immune response that gives rise to asthma,<br />

we will obtain the knowledge and tools necessary for the<br />

design <strong>of</strong> generally applicable vaccines and therapies for<br />

the treatment <strong>of</strong> individuals with established disease.<br />

Response<br />

The cytokine interleukin-4 (IL-4) is thought to be critical<br />

for the development <strong>of</strong> Th2 CD4+ T cells that respond to<br />

parasitic infections and mediate allergic disease. We have<br />

used genetically modified mice whose Th2 cells fluoresce<br />

in a harmless way when they become active to quantify<br />

the IL-4 dependency <strong>of</strong> the Th2 immune response to the<br />

nematode parasite Nippostrongylus brasiliensis.<br />

In 2006 we confirmed that IL-4 and STAT6, previously<br />

thought to be essential for inducing a Th2 immune<br />

response, were not required for Th2 development in our<br />

asthma and allergy models. IL-4 and STAT6 are however<br />

necessary for recruitment <strong>of</strong> inflammatory cells to the<br />

lung. Contrary to recent theories, we also showed that IL-2<br />

and STAT5a signalling does not lead to Th2 induction in vitro.<br />

These data indicate that the differentiation <strong>of</strong> naïve CD4 T<br />

cells to Th2 cells occurs entirely independently <strong>of</strong> IL-4<br />

and STAT6, and that parasite and allergen challenges<br />

induce novel pathways for the selective induction <strong>of</strong> Th2<br />

immune responses.<br />

Group Members<br />

Pr<strong>of</strong> Graham Le Gros, Mali Camberis, Marina Harvie, Melanie<br />

Prout, Dr Debbie Scarlett (to May), Dr Bridget Stocker,<br />

Shiau-Choot Tang, Nicholas van Panhuys

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!